Professional Documents
Culture Documents
Textbook Ebook Biomaterials For 3D Tumor Modeling Materials Today 1St Edition Subhas Kundu Editor All Chapter PDF
Textbook Ebook Biomaterials For 3D Tumor Modeling Materials Today 1St Edition Subhas Kundu Editor All Chapter PDF
SUBHAS C. KUNDU
3B’s Research Group, I3Bs Research Institute on Biomaterials, Biodegradables and Biomimetics, University of
Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine,
Guimarães, Portugal
ICVS/3B’s PT Government Associate Laboratory, Braga/Guimarães, Portugal
RUI L. REIS
3B’s Research Group, I3Bs Research Institute on Biomaterials, Biodegradables and Biomimetics, University of
Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine,
Guimarães, Portugal
ICVS/3B’s PT Government Associate Laboratory, Braga/Guimarães, Portugal
Elsevier
Radarweg 29, PO Box 211, 1000 AE Amsterdam, Netherlands
The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom
50 Hampshire Street, 5th Floor, Cambridge, MA 02139, United States
Copyright © 2020 Elsevier Inc. All rights reserved.
No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical,
including photocopying, recording, or any information storage and retrieval system, without permission in writing from the
publisher. Details on how to seek permission, further information about the Publisher’s permissions policies and our
arrangements with organizations such as the Copyright Clearance Center and the Copyright Licensing Agency, can be found
at our website: www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright by the Publisher (other than as may
be noted herein).
Notices
Knowledge and best practice in this field are constantly changing. As new research and experience broaden our
understanding, changes in research methods, professional practices, or medical treatment may become necessary.
Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any
information, methods, compounds, or experiments described herein. In using such information or methods they should be
mindful of their own safety and the safety of others, including parties for whom they have a professional responsibility.
To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors, assume any liability for any
injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or
operation of any methods, products, instructions, or ideas contained in the material herein.
British Library Cataloguing-in-Publication Data
A catalogue record for this book is available from the British Library
Library of Congress Cataloging-in-Publication Data
A catalog record for this book is available from the Library of Congress
ISBN: 978-0-12-818128-7
v
vi Contents
5.5 Cell-derived matrices and cell morphodynamic 8.5 Microvessels on a chip 184
characterization 123 8.6 Future perspectives 186
5.6 Cell-derived matrix capture relevant processes Acknowledgments 186
involved in neuroblastoma malignancy 125 References 187
5.7 Conclusions 126
Acknowledgments 126 9. Metastasis in three-dimensional
References 126 biomaterials 191
Banani Kundu, Rui L. Reis and Subhas C. Kundu
6. 3D culture systems as models for solid
tumors and cancer metabolism 131 9.1 Why biomaterial is needed in cancer
Sónia Pires Celeiro, Fátima Baltazar and Marta Viana-Pereira modeling? 191
9.2 Biomaterials employed in tumor ECM
Abbreviations 131 modeling 193
6.1 Introduction 132 9.3 Properties of cell surrounding matrix/niche
6.2 Solid tumors: tumor microenvironment and contribute to tumor cell migration 197
tumorigenesis 133 9.4 Biomaterial-based stepwise modeling of cancer
6.3 Cancer metabolism: influence in tumor metastasis in vitro 199
microenvironment 135 9.5 Biomaterial-based in vitro models of cancer
6.4 Solid tumors in vitro models 139 dormancy and reactivation 208
6.5 3D cell culture systems in cancer research 143 9.6 Concluding remarks 209
6.6 3D cell culture systems for study cancer Acknowledgments 210
metabolism 146 References 210
6.7 Conclusions 148
Acknowledgments 149 10. 3D cancer spheroids and
Conflict of interest 149 microtissues 217
References 149
Virginia Brancato, Rui L. Reis and Subhas C. Kundu
Enrico Almici Nanobioengineering Group, Fátima Baltazar Life and Health Science
Institute for Bioengineering of Catalonia Research Institute (ICVS), School of
(IBEC), The Barcelona Institute of Science and Medicine, University of Minho, Braga,
Technology (BIST), Barcelona, Spain; Portugal; ICVS/3B’s PT Government
Department of Electronics and Biomedical Associate Laboratory, Braga/Guimarães,
Engineering, University of Barcelona, Portugal
Barcelona, Spain; Networking Biomedical Ana I. Barbosa 3B’s Research Group, I3Bs
Investigation Center for Bioengineering, Research Institute on Biomaterials,
Biomaterials and Nanomedicine (CIBER- Biodegradables and Biomimetics, University of
BBN), Madrid, Spain Minho, Headquarters of the European Institute
M. Alonso Nano-Oncology and Translational of Excellence on Tissue Engineering and
Therapeutics Unit, Health Research Institute Regenerative Medicine, Guimarães, Portugal;
of Santiago de Compostela (IDIS), SERGAS, ICVS/3B’s PT Government Associate
Santiago de Compostela, Spain; Cancer Laboratory, Braga/Guimarães, Portugal
Research Network (CIBERONC), Spain
Virginia Brancato 3B’s Research Group, I3Bs
Sara Amorim 3B’s Research Group, I3Bs Research Institute on Biomaterials,
Research Institute on Biomaterials, Biodegradables and Biomimetics, University of
Biodegradables and Biomimetics, University Minho, Headquarters of the European Institute
of Minho, Headquarters of the European of Excellence on Tissue Engineering and
Institute of Excellence on Tissue Engineering Regenerative Medicine, Guimarães, Portugal;
and Regenerative Medicine, Guimarães, ICVS/3B’s PT Government Associate
Portugal; ICVS/3B’s - PT Government Laboratory, Braga/Guimarães, Portugal
Associate Laboratory, Braga/Guimarães,
David Caballero 3B’s Research Group, I3Bs
Portugal
Research Institute on Biomaterials,
Esteban A. Astudillo-Ortiz 3B’s Research Biodegradables and Biomimetics, University
Group, I3Bs Research Institute on of Minho, Headquarters of the European
Biomaterials, Biodegradables and Institute of Excellence on Tissue Engineering
Biomimetics, University of Minho, and Regenerative Medicine, Guimarães,
Guimarães, Portugal; ICVS/3B’s PT Portugal; ICVS/3B’s PT Government
Government Associate Laboratory, Braga/ Associate Laboratory, Braga/Guimarães,
Guimarães, Portugal; GIRO Research Group Portugal
in Oral Rehabilitation, University of Cuenca,
Cuenca, Ecuado Paolo Caccavale University of Basilicata,
Pedro S. Babo 3B’s Research Group, I3Bs College of Engineering, Modeling and
Research Institute on Biomaterials, Prototyping Laboratory—ModProLab,
Biodegradables and Biomimetics, University of Potenza, Italy
Minho, Headquarters of the European Institute Bo Cai Research Center for Tissue Engineering
of Excellence on Tissue Engineering and and Regenerative Medicine, Union Hospital,
Regenerative Medicine, Guimarães, Portugal; Tongji Medical College, Huazhong
ICVS/3B’s PT Government Associate University of Science and Technology,
Laboratory, Braga/Guimarães, Portugal Wuhan, P.R. China
xi
xii List of Contributors
xvii
xviii Preface
1
Trends in biomaterials for
three-dimensional cancer modeling
David Caballero1,2, Rui L. Reis1,2 and Subhas C. Kundu1,2
1
3B’s Research Group, I3Bs Research Institute on Biomaterials, Biodegradables and
Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on
Tissue Engineering and Regenerative Medicine, Guimarães, Portugal 2ICVS/3B’s PT
Government Associate Laboratory, Braga/Guimarães, Portugal
Abbreviations
2D Two-dimensions
3D Three-dimensions
4D Four-dimensions
ADMET Adsorption, distribution, metabolism, excretion, and toxicity
CAFs Cancer-associated fibroblasts
CDMs Cell-derived matrices
CTCs Circulating tumor cells
ECM Extracellular matrix
EMEA European Medicines Agency
EMT Epithelial-to-mesenchymal transition
EPR Enhanced permeability and retention
FDA Federal drug agency
HA Hyaluronic acid
HUVEC Human umbilical vein endothelial cells
MMPs Matrix metalloproteases
PDMS Polydimethylsiloxane
PEG Poly(ethylene glycol)
TAMs Tumor-associated macrophages
TME Tumor microenvironment
ToC Tumor-on-a-chip
VEGF Vascular endothelial growth factor